These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26663873)

  • 1. Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies.
    Zhang C; Yan Y; Zou Q; Chen J; Li C
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):13-21. PubMed ID: 26663873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles.
    Islam T; Josephson L
    Cancer Biomark; 2009; 5(2):99-107. PubMed ID: 19414927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.
    Thomas R; Park IK; Jeong YY
    Int J Mol Sci; 2013 Jul; 14(8):15910-30. PubMed ID: 23912234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
    Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
    Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of human pancreatic cancer xenograft labeled with superparamagnetic iron oxide in nude mice.
    Wu CY; Pu Y; Liu G; Shao Y; Ma QS; Zhang XM
    Contrast Media Mol Imaging; 2012; 7(1):51-8. PubMed ID: 22344880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
    Wen M; Li B; Ouyang Y; Luo Y; Li S
    Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications.
    Jin R; Lin B; Li D; Ai H
    Curr Opin Pharmacol; 2014 Oct; 18():18-27. PubMed ID: 25173782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
    Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
    Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
    Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
    J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging.
    Zhang Z; Mascheri N; Dharmakumar R; Fan Z; Paunesku T; Woloschak G; Li D
    Cytotherapy; 2009; 11(1):43-51. PubMed ID: 18956269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
    Sharifi S; Seyednejad H; Laurent S; Atyabi F; Saei AA; Mahmoudi M
    Contrast Media Mol Imaging; 2015; 10(5):329-55. PubMed ID: 25882768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.
    Zuo HD; Yao WW; Chen TW; Zhu J; Zhang JJ; Pu Y; Liu G; Zhang XM
    Biomed Res Int; 2014; 2014():852352. PubMed ID: 24977163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
    Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
    J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
    Zhang B; Yang B; Zhai C; Jiang B; Wu Y
    Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxide nanoparticle probes for molecular imaging.
    Thorek DL; Chen AK; Czupryna J; Tsourkas A
    Ann Biomed Eng; 2006 Jan; 34(1):23-38. PubMed ID: 16496086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ENO1-targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging.
    Wang L; Yin H; Bi R; Gao G; Li K; Liu HL
    J Cell Mol Med; 2020 May; 24(10):5751-5757. PubMed ID: 32285549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent.
    Kojima H; Mukai Y; Yoshikawa M; Kamei K; Yoshikawa T; Morita M; Inubushi T; Yamamoto TA; Yoshioka Y; Okada N; Seino S; Nakagawa S
    Bioconjug Chem; 2010 Jun; 21(6):1026-31. PubMed ID: 20446679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
    Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
    Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.